32 research outputs found
Colorimetric biomimetic sensor systems based on molecularly imprinted polymer membranes for highly-selective detection of phenol in environmental samples
Aim. Development of an easy-to-use colorimetric sensor system for fast and accurate detection of phenol in envi- ronmental samples. Methods. Technique of molecular imprinting, method of in situ polymerization of molecularly imprinted polymer membranes. Results. The proposed sensor is based on free-standing molecularly imprinted polymer (MIP) membranes, synthesized by in situ polymerization, and having in their structure artificial binding sites capable of selective phenol recognition. The quantitative detection of phenol, selectively adsorbed by the MIP membranes, is based on its reaction with 4-aminoantipyrine, which gives a pink-colored product. The intensity of staining of the MIP membrane is proportional to phenol concentration in the analyzed sample. Phenol can be detected within the range 50 nM–10 mM with limit of detection 50 nM, which corresponds to the concentrations that have to be detected in natural and waste waters in accordance with environmental protection standards. Stability of the MIP-membrane-based sensors was assessed during 12 months storage at room temperature. Conclusions. The sensor system provides highly-selective and sensitive detection of phenol in both mo- del and real (drinking, natural, and waste) water samples. As compared to traditional methods of phenol detection, the proposed system is characterized by simplicity of operation and can be used in non-laboratory conditions.ΠΠ΅ΡΠ°. Π ΠΎΠ·ΡΠΎΠ±ΠΊΠ° ΠΏΡΠΎΡΡΠΈΡ
Ρ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΠΊΠΎΠ»ΠΎΡΠΈΠΌΠ΅ΡΡΠΈΡΠ½ΠΈΡ
ΡΠ΅Π½ΡΠΎΡΠ½ΠΈΡ
ΡΠΈΡΡΠ΅ΠΌ Π΄Π»Ρ ΡΠ²ΠΈΠ΄ΠΊΠΎΠ³ΠΎ Ρ ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π²ΠΈΠ·Π½Π°ΡΠ΅Π½Π½Ρ ΡΠ΅Π½ΠΎΠ»Ρ Ρ Π·ΡΠ°Π·ΠΊΠ°Ρ
ΡΠ· Π΄ΠΎΠ²ΠΊΡΠ»Π»Ρ. ΠΠ΅ΡΠΎΠ΄ΠΈ. ΠΠ΅ΡΠΎΠ΄ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠ³ΠΎ ΡΠΌΠΏΡΠΈΠ½ΡΠΈΠ½Π³Ρ, ΠΌΠ΅ΡΠΎΠ΄ ΠΏΠΎΠ»ΡΠΌΠ΅ΡΠΈΠ·Π°ΡΡΡ in situ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ ΡΠΌΠΏΡΠΈΠ½ΡΠΎΠ²Π°Π½ΠΈΡ
ΠΏΠΎΠ»ΡΠΌΠ΅ΡΠ½ΠΈΡ
(ΠΠΠ) ΠΌΠ΅ΠΌΠ±ΡΠ°Π½. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΠΈ. ΠΠ°ΠΏΡΠΎΠΏΠΎΠ½ΠΎΠ²Π°Π½ΠΈΠΉ ΡΠ΅Π½ΡΠΎΡ ΡΡΠ²ΠΎΡΠ΅Π½ΠΎ Π½Π° ΠΎΡΠ½ΠΎΠ²Ρ ΠΠΠ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½, ΡΠΈΠ½ΡΠ΅Π·ΠΎΠ²Π°Π½ΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΡΠΌΠ΅ΡΠΈΠ·Π°ΡΡΡ in situ, ΡΠΊΡ ΠΌΠ°ΡΡΡ Ρ ΡΠ²ΠΎΡΠΉ ΡΡΡΡΠΊΡΡΡΡ ΡΡΡΡΠ½Ρ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠ½Ρ ΡΠ°ΠΉΡΠΈ Π·Π²βΡΠ·ΡΠ²Π°Π½Π½Ρ ΡΠ΅Π½ΠΎΠ»Ρ. ΠΡΠ»ΡΠΊΡΡΠ½Π΅ Π²ΠΈΠ·Π½Π°ΡΠ΅Π½Π½Ρ ΡΠ΅Π½ΠΎΠ»Ρ, ΡΠ΅Π»Π΅ΠΊΡΠΈΠ²Π½ΠΎ Π°Π΄ΡΠΎΡΠ±ΠΎΠ²Π°Π½ΠΎΠ³ΠΎ ΠΠΠ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π°ΠΌΠΈ, Π³ΡΡΠ½ΡΡΡΡΡΡΡ Π½Π° Π΄Π΅ΡΠ΅ΠΊΡΡΡ Π·Π°Π±Π°ΡΠ²Π»Π΅Π½ΠΎΠ³ΠΎ Ρ ΠΌΠ°Π»ΠΈΠ½ΠΎΠ²ΠΈΠΉ ΠΊΠΎΠ»ΡΡ ΠΏΡΠΎΠ΄ΡΠΊΡΡ ΠΉΠΎΠ³ΠΎ ΡΠ΅Π°ΠΊΡΡΡ Π· 4-Π°ΠΌΡΠ½ΠΎΠ°Π½ΡΠΈΠΏΡΡΠΈΠ½ΠΎΠΌ. ΠΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΡΡΡΡ Π·Π°Π±Π°ΡΠ²Π»Π΅Π½Π½Ρ ΠΠΠ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ Ρ ΠΏΡΠΎΠΏΠΎΡΡΡΠΉΠ½ΠΎΡ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΡΡ ΡΠ΅Π½ΠΎΠ»Ρ Π² Π°Π½Π°Π»ΡΠ·ΠΎΠ²Π°Π½ΠΎΠΌΡ Π·ΡΠ°Π·ΠΊΡ. Π€Π΅Π½ΠΎΠ» Π΄Π΅ΡΠ΅ΠΊΡΡΡΡΡΡΡ Ρ Π΄ΡΠ°ΠΏΠ°Π·ΠΎΠ½Ρ 50 Π½Π–10 ΠΌΠ, ΡΠΎ Π²ΡΠ΄ΠΏΠΎΠ²ΡΠ΄Π°Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΡΡΠΌ, ΡΠΊΡ Π½Π΅ΠΎΠ±Ρ
ΡΠ΄Π½ΠΎ Π²ΠΈΡΠ²Π»ΡΡΠΈ Ρ ΠΏΡΠΈΡΠΎΠ΄Π½ΠΈΡ
Ρ ΡΡΡΡΠ½ΠΈΡ
Π²ΠΎΠ΄Π°Ρ
. Π‘ΡΠ°Π±ΡΠ»ΡΠ½ΡΡΡΡ ΡΠ΅Π½ΡΠΎΡΠ½ΠΈΡ
ΡΠΈΡΡΠ΅ΠΌ Π½Π° ΠΎΡΠ½ΠΎΠ²Ρ ΠΠΠ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΡΡΠ°Π½ΠΎΠ²ΠΈΡΡ12 ΠΌΡΡΡΡΡΠ² Π·Π° ΠΊΡΠΌΠ½Π°ΡΠ½ΠΎΡ ΡΠ΅ΠΌΠΏΠ΅ΡΠ°ΡΡΡΠΈ. ΠΠΈΡΠ½ΠΎΠ²ΠΊΠΈ. Π‘Π΅Π½ΡΠΎΡΠ½Ρ ΡΠΈΡΡΠ΅ΠΌΠΈ Π·Π°Π±Π΅Π·ΠΏΠ΅ΡΡΡΡΡ Π²ΠΈΡΠΎΠΊΠΎΡΠ΅Π»Π΅ΠΊΡΠΈΠ²Π½ΠΈΠΉ Ρ ΡΡΡΠ»ΠΈΠ²ΠΈΠΉ Π°Π½Π°Π»ΡΠ· ΡΠ΅Π½ΠΎΠ»Ρ ΡΠΊ Ρ ΠΌΠΎΠ΄Π΅Π»ΡΠ½ΠΈΡ
, ΡΠ°ΠΊ Ρ ΡΠ΅Π°Π»ΡΠ½ΠΈΡ
Π·ΡΠ°Π·ΠΊΠ°Ρ
(ΠΏΠΈΡΠ½Π°, ΠΏΡΠΈΡΠΎΠ΄Π½Π°, ΡΡΡΡΠ½Π° Π²ΠΎΠ΄Π°). ΠΠΎΡΡΠ²Π½ΡΠ½ΠΎ Π΄ΠΎ ΡΡΠ°Π΄ΠΈΡΡΠΉΠ½ΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΡΠ² Π²ΠΈΠ·Π½Π°ΡΠ΅Π½Π½Ρ ΡΠ΅Π½ΠΎΠ»Ρ ΠΏΡΠΎΠΏΠΎΠ½ΠΎΠ²Π°Π½Π° ΡΠΈΡΡΠ΅ΠΌΠ° Ρ ΠΏΡΠΎΡΡΠΎΡ Ρ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΡΠ° ΠΌΠΎΠΆΠ΅ Π±ΡΡΠΈ Π·Π°ΡΡΠΎΡΠΎΠ²Π°Π½Π° Π·Π° ΠΏΠΎΠ»ΡΠΎΠ²ΠΈΡ
ΡΠΌΠΎΠ².Π¦Π΅Π»Ρ. Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΠΏΡΠΎΡΡΡΡ
Π² ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΠ»ΠΎΡΠΈΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅Π½ΡΠΎΡΠ½ΡΡ
ΡΠΈΡΡΠ΅ΠΌ Π΄Π»Ρ Π±ΡΡΡΡΠΎΠ³ΠΎ ΠΈ ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΠ΅Π½ΠΎΠ»Π° Π² ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ
ΠΈΠ· ΠΎΠΊΡΡΠΆΠ°ΡΡΠ΅ΠΉ ΡΡΠ΅Π΄Ρ. ΠΠ΅ΡΠΎΠ΄Ρ. ΠΠ΅ΡΠΎΠ΄ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΏΡΠΈΠ½ΡΠΈΠ½Π³Π°, ΠΌΠ΅ΡΠΎΠ΄ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠΈΠ·Π°ΡΠΈΠΈ in situ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ ΠΈΠΌΠΏΡΠΈΠ½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ½ΡΡ
(ΠΠΠ) ΠΌΠ΅ΠΌΠ±ΡΠ°Π½. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π½ΡΠΉ ΡΠ΅Π½ΡΠΎΡ ΡΠΎΠ·Π΄Π°Π½ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΠΠ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½, ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠΈΠ·Π°ΡΠΈΠΈ in situ, ΠΈΠΌΠ΅ΡΡΠΈΡ
Π² ΡΠ²ΠΎΠ΅ΠΉ ΡΡΡΡΠΊΡΡΡΠ΅ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠ½ΡΠ΅ ΡΠ°ΠΉΡΡ ΡΠ²ΡΠ·ΡΠ²Π°Π½ΠΈΡ ΡΠ΅Π½ΠΎΠ»Π°. ΠΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠ΅Π½ΠΎΠ»Π°, ΡΠ΅Π»Π΅ΠΊΡΠΈΠ²Π½ΠΎ Π°Π΄ΡΠΎΡΠ±ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΠΠ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π°ΠΌΠΈ, ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΎ Π½Π° Π΄Π΅ΡΠ΅ΠΊΡΠΈΠΈ ΠΎΠΊΡΠ°ΡΠ΅Π½Π½ΠΎΠ³ΠΎ Π² ΠΌΠ°Π»ΠΈΠ½ΠΎΠ²ΡΠΉ ΡΠ²Π΅Ρ ΠΏΡΠΎΠ΄ΡΠΊΡΠ° Π΅Π³ΠΎ ΡΠ΅Π°ΠΊΡΠΈΠΈ Ρ 4-Π°ΠΌΠΈΠ½ΠΎΠ°Π½ΡΠΈΠΏΠΈΡΠΈΠ½ΠΎΠΌ. ΠΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΡ ΠΎΠΊΡΠ°ΡΠΈΠ²Π°Π½ΠΈΡ ΠΠΠ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΏΡΠΎΠΏΠΎΡΡΠΈΠΎΠ½Π°Π»ΡΠ½Π° ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΡΠ΅Π½ΠΎΠ»Π° Π² Π°Π½Π°Π»ΠΈΠ·ΠΈΡΡΠ΅ΠΌΠΎΠΌ ΠΎΠ±ΡΠ°Π·ΡΠ΅. Π€Π΅Π½ΠΎΠ» ΠΌΠΎΠΆΠ½ΠΎ Π΄Π΅ΡΠ΅ΠΊΡΠΈΡΠΎΠ²Π°ΡΡ Π² ΠΏΡΠ΅Π΄Π΅Π»Π°Ρ
50 Π½Π–10 ΠΌΠ, ΡΡΠΎ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡΠΌ, ΠΊΠΎΡΠΎΡΡΠ΅ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ Π²ΡΡΠ²Π»ΡΡΡ Π² ΠΏΡΠΈΡΠΎΠ΄Π½ΡΡ
ΠΈ ΡΡΠΎΡΠ½ΡΡ
Π²ΠΎΠ΄Π°Ρ
. Π‘ΡΠ°Π±ΠΈΠ»ΡΠ½ΠΎΡΡΡ ΡΠ΅Π½ΡΠΎΡΠ½ΡΡ
ΡΠΈΡΡΠ΅ΠΌ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΠΠ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΡΠΎΡΡΠ°Π²Π»ΡΠ΅Ρ 12 ΠΌΠ΅ΡΡΡΠ΅Π² ΠΏΡΠΈ ΠΊΠΎΠΌΠ½Π°ΡΠ½ΠΎΠΉ ΡΠ΅ΠΌΠΏΠ΅ΡΠ°ΡΡΡΠ΅. ΠΡΠ²ΠΎΠ΄Ρ. Π‘Π΅Π½ΡΠΎΡΠ½ΡΠ΅ ΡΠΈΡΡΠ΅ΠΌΡ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°ΡΡ Π²ΡΡΠΎΠΊΠΎΡΠ΅Π»Π΅ΠΊΡΠΈΠ²Π½ΡΠΉ ΠΈ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΠ΅Π½ΠΎΠ»Π° ΠΊΠ°ΠΊ Π² ΠΌΠΎΠ΄Π΅Π»ΡΠ½ΡΡ
, ΡΠ°ΠΊ ΠΈ ΡΠ΅Π°Π»ΡΠ½ΡΡ
ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ
(ΠΏΠΈΡΡΠ΅Π²Π°Ρ, ΠΏΡΠΈΡΠΎΠ΄Π½Π°Ρ ΠΈ ΡΡΠΎΡΠ½Π°Ρ Π²ΠΎΠ΄Π°). ΠΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΡΠΌΠΈ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΠ΅Π½ΠΎΠ»Π° ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π½Π°Ρ ΡΠΈΡΡΠ΅ΠΌΠ° ΠΏΡΠΎΡΡΠ° Π² ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ ΠΈ ΠΌΠΎΠΆΠ΅Ρ ΠΏΡΠΈΠΌΠ΅Π½ΡΡΡΡΡ Π² ΠΏΠΎΠ»Π΅Π²ΡΡ
ΡΡΠ»ΠΎΠ²ΠΈΡΡ
Biosensors based on conductometric detection
The present paper is a self-review on the development of about 20 conductometric biosensors based on planar electrodes and containing different biological material (enzymes, cells, antibodies), bio-mimics or synthetic membranes, including Imprinting polymers, as a sensitive element. Highly specific, sensitive, simple, fast and cheap determination of different analytes makes them promising for needs of medicine, biotechnology, environmental control, agriculture and food industry. Non-specific interference of back-ground ions may be overcome by the differential mode of measurement, the usage of rather concentrated sample buffer and additional negatively or positively charged membranes, which decrease buffer capacity influence and extend a dynamic range of sensors response. For development of easy-to-use small conductometric immunosensors several approaches seem to be promising: i) the usage of polyaniline as electroconductive label for antibodies detection in competitive electroimmunoassay; ii) the elaboration of multilayer structures with phtalocyanine films; iii) the usage of acrylic copolymeric membranes. The advantages and disadvantages of conductometric biosensors created are discussed. For future commercialisation our effort are aimed to unite a thin-film technology with membranes deposition and to find the ways of membrane stabilisation, including bio-mimics creation, utilisation of bioaffinity polymeric membranes, imprinting polymers etc.ΠΠ³Π»ΡΠ΄ ΠΏΡΠΈΡΠ²ΡΡΠ΅Π½ΠΎ Π°Π½Π°Π»ΡΠ·Ρ Π²Π»Π°ΡΠ½ΠΈΡ
ΡΠΎΠ±ΡΡ Π· ΡΠΎΠ·ΡΠΎΠ±ΠΊΠΈ Π±Π»ΠΈΠ·ΡΠΊΠΎ 20 ΠΊΠΎΠ½Π΄ΡΠΊΡΠΎΠΌΠ΅ΡΡΠΈΡΠ½ΠΈΡ
Π±ΡΠΎΡΠ΅Π½ΡΠΎΡΡΠ² Π½Π° ΠΎΡΠ½ΠΎΠ²Ρ ΠΏΠ»Π°Π½Π°ΡΠ½ΠΈΡ
Π΅Π»Π΅ΠΊΡΡΠΎΠ΄ΡΠ² ΡΠ° ΡΡΠ·Π½ΠΎΠΌΠ°Π½ΡΡΠ½ΠΎΠ³ΠΎ Π±ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΡΠ°Π»Ρ (ΡΠ΅ΡΠΌΠ΅Π½ΡΠΈ, ΠΊΠ»ΡΡΠΈΠ½ΠΈ, Π°Π½ΡΠΈΡΡΠ»Π°), ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ½ΠΈΡ
ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΡΠΊ ΡΡΡΠ»ΠΈΠ²ΠΈΡ
Π΅Π»Π΅ΠΌΠ΅Π½ΡΡΠ². ΠΠΈΡΠΎΠΊΠ° ΡΠ΅Π»Π΅ΠΊΡΠΈΠ²Π½ΡΡΡΡ, ΡΡΡΠ»ΠΈΠ²ΡΡΡΡ, Π½ΠΈΠ·ΡΠΊΠ° ΡΡΠ½Π°, ΠΏΡΠΎΡΡΠΎΡΠ° ΡΠ° Π΅ΠΊΡΠΏΡΠ΅ΡΠ½ΡΡΡΡ Π²ΠΈΠ·Π½Π°ΡΠ΅Π½Π½Ρ ΡΡΠ·Π½ΠΎΠΌΠ°Π½ΡΡΠ½ΠΈΡ
ΡΠ΅ΡΠΎΠ²ΠΈΠ½ ΡΠΎΠ±Π»ΡΡΡ Π±ΡΠΎΡΠ΅Π½ΡΠΎΡΠΈ Π½Π΅ΠΎΠ±Ρ
ΡΠ΄Π½ΠΈΠΌΠΈ Π΄Π»Ρ ΠΏΠΎΡΡΠ΅Π± ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΠΈ, Π±ΡΠΎΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΡΡ, Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈ, ΡΡΠ»ΡΡΡΠΊΠΎΠ³ΠΎ Π³ΠΎΡΠΏΠΎΠ΄Π°ΡΡΡΠ²Π° ΡΠ° Ρ
Π°ΡΡΠΎΠ²ΠΎΡ ΠΏΡΠΎΠΌΠΈΡΠ»ΠΎΠ²ΠΎΡΡΡ. ΠΡΠΈ Π°Π½Π°Π»ΡΠ·Ρ ΡΠ΅Π°Π»ΡΠ½ΠΈΡ
Π·ΡΠ°Π·ΠΊΡΠ² Π½Π΅ΡΠΏΠ΅ΡΠΈΡΡΡΠ½ΠΈΠΉ Π²ΠΏΠ»ΠΈΠ² ΡΠΎΠ½ΠΎΠ²ΠΈΡ
Π΅Π»Π΅ΠΊΡΡΠΎΠ»ΡΡΡΠ² ΠΌΠΎΠΆΠ½Π° ΡΡΡΡΡΠ²ΠΎ Π·ΠΌΠ΅Π½ΡΠΈΡΠΈ Π·Π°Π²Π΄ΡΠΊΠΈ Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ Π΄ΠΈΡΠ΅ΡΠ΅Π½ΡΡΠΉΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΆΠΈΠΌΡ Π²ΠΈΠΌΡΡΡΠ²Π°Π½Ρ, Π±ΡΠ»ΡΡ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠΎΠ²Π°Π½ΠΈΡ
Π±ΡΡΠ΅ΡΠ½ΠΈΡ
ΡΠΎΠ·ΡΠΈΠ½ΡΠ², Π° ΡΠ°ΠΊΠΎΠΆ Π΄ΠΎΠ΄Π°ΡΠΊΠΎΠ²ΠΈΡ
Π½Π΅Π³Π°ΡΠΈΠ²Π½ΠΎ ΡΠΈ ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΠΎ Π·Π°ΡΡΠ΄ΠΆΠ΅Π½ΠΈΡ
ΠΌΠ΅ΠΌΠ±ΡΠ°Π½, ΡΠΊΡ Π·Π°ΠΏΠΎΠ±ΡΠ³Π°ΡΡΡ Π²ΠΏΠ»ΠΈΠ²ΠΎΠ²Ρ Π±ΡΡΠ΅ΡΠ½ΠΎΡ ΡΠΌΠ½ΠΎΡΡΡ ΡΠ° ΡΠΎΠ½Π½ΠΎΡ ΡΠΈΠ»ΠΈ ΡΠΎΠ·ΡΠΈΠ½ΡΠ² Ρ ΡΠΎΠ·ΡΠΈΡΡΡΡΡ Π΄ΠΈΠ½Π°ΠΌΡΡΠ½ΠΈΠΉ Π΄ΡΠ°ΠΏΠ°Π·ΠΎΠ½ ΡΠΎΠ±ΠΎΡΠΈ ΡΠ΅Π½ΡΠΎΡΡΠ². ΠΠ»Ρ ΡΡΠ²ΠΎΡΠ΅Π½Π½Ρ ΠΌΡΠ½ΡΠ°ΡΡΡΠ½ΠΈΡ
ΡΠΌΡΠ½ΠΎΡΠ΅Π½ΡΠΎΡΡΠ² Π±ΡΠ»ΠΎ Π·Π°ΠΏΡΠΎΠΏΠΎΠ½ΠΎΠ²Π°Π½ΠΎ ΡΠ°ΠΊΡ ΠΏΡΠ΄Ρ
ΠΎΠ΄ΠΈ: Π°) Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ ΠΏΠΎΠ»ΡΠ°Π½ΡΠ»ΡΠ½Ρ ΡΠΊ Π΅Π»Π΅ΠΊΡΡΠΎΠΏΡΠΎΠ²ΡΠ΄Π½ΠΎΡ ΠΌΡΡΠΊΠΈ ΠΏΡΠΈ Π²ΠΈΠ· Π½Π°ΡΠ΅ ΠΏΠ½Ρ Π°Π½ΡΠΈΡΡΠ» Ρ ΠΊΠΎΠ½ΠΊΡΡΠ΅Π½ΡΠ½ΠΎΠΌΡ ΡΠΌΡΠ½ΠΎΠ°Π½Π°Π»ΡΠ·Ρ: Π±) ΡΡΠ²ΠΎΡΠ΅Π½Π½Ρ Π±Π°Π³Π°ΡΠΎΡΠ°ΡΠΎΠ²ΠΈΡ
ΡΡΡΡΠΊΡΡΡ Π· ΠΏΠ»ΡΠ²ΠΊΠ°ΠΌΠΈ ΡΡΠ°Π»ΠΎΡΡΠ°Π½ΡΠ½Ρ; Π²) Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½Ρ Π°ΠΊΡΠΈΠ»ΠΎΠ²ΠΈΡ
ΡΠΎΠΏΠΎΠ»ΡΠΌΠ΅ΡΠ½ΠΈΡ
ΠΌΠ΅ΠΌΠ±ΡΠ°Π½. ΠΠ±Π³ΠΎΠ²ΠΎΡΠ΅Π½ΠΎ ΠΏΠ΅ΡΠ΅Π²Π°Π³ΠΈ ΡΠ° Π½Π΅Π΄ΠΎΠ»ΡΠΊΠΈ ΡΠΎΠ·ΡΠΎΠ±Π»Π΅Π½ΠΈΡ
ΠΊΠΎΠ½Π΄ΡΠΊΡΠΎΠΌΠ΅ΡΡΠΈΡΠ½ΠΈΡ
Π±ΡΠΎΡΠ΅Π½ΡΠΎΡΡΠ². ΠΠΎΠ΄Π°Π»ΡΡΠ° ΠΊΠΎΠΌΠ΅ΡΡΡΠ°Π»ΡΠ·Π°ΡΡΡ ΡΠ°ΠΊΠΈΡ
ΠΏΡΠΈΠ»Π°Π΄ΡΠ² ΠΏΠΎΠ²'ΡΠ·Π°Π½Π° Π· ΠΏΠΎΡΡΠΊΠΎΠΌ ΡΠ»ΡΡ
ΡΠ² ΡΡΠ°Π±ΡΠ»ΡΠ·Π°ΡΡΡ ΡΡΡΠ»ΠΈΠ²ΠΈΡ
ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΡΠ° ΡΡΠΌΡΡΠ΅Π½Π½Ρ ΡΠΎΠ½ΠΊΠΎΠΏΠ»ΡΠ²ΠΊΠΎΠ²ΠΈΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΡΠΉ Π· Π½Π°Π½Π΅ΡΠ΅Π½Π½ΡΠΌ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ Ρ ΡΠ΄ΠΈΠ½ΠΎΠΌΡ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΠΌΡ ΡΠΈΠΊΠ»Ρ.ΠΠ±Π·ΠΎΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½ Π°Π½Π°Π»ΠΈΠ·Ρ ΡΠΎΠ±ΡΡΠ²Π΅Π½Π½ΡΡ
ΡΠ°Π±ΠΎΡ ΠΏΠΎ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ΅ ΠΎΠΊΠΎΠ»ΠΎ 20 ΠΊΠΎΠ½Π΄ΡΠΊΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π±ΠΈΠΎΡΠ΅Π½ΡΠΎΡΠΎΠ² Π½Π°. ΠΎΡΠ½ΠΎΠ²Π΅ ΠΏΠ»Π°Π½Π°ΡΠ½ΡΡ
ΡΠ»Π΅ΠΊΡΡΠΎΠ΄ΠΎΠ² ΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠ³ΠΎ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π°, (ΡΠ΅ΡΠΌΠ΅Π½ΡΡ, ΠΊΠ»Π΅ΡΠΊΠΈ, Π°Π½ΡΠΈΡΠ΅Π»Π°) ΠΈ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΎ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠ»Π΅ΠΌΠ΅Π½ΡΠΎΠ². ΠΡΡΠΎΠΊΠ°Ρ ΡΠ΅Π»Π΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ, ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ, Π΄Π΅ΡΠ΅Π²ΠΈΠ·Π½Π°, ΠΏΡΠΎΡΡΠΎΡΠ° ΠΈ Π±ΡΡΡΡΠΎΡΠ° ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
Π²Π΅ΡΠ΅ΡΡΠ² Π΄Π΅Π»Π°ΡΡ Π±ΠΈΠΎΡΠ΅Π½ΡΠΎΡΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡΠΌΠΈ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Π΅, Π±ΠΈΠΎΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ, ΡΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ, ΡΠ΅Π»ΡΡΠΊΠΎΠΌ Ρ
ΠΎΠ·ΡΠΉΡΡΠ²Π΅ ΠΈ ΠΏΠΈΡΠ΅Π²ΠΎΠΉ ΠΏΡΠΎΠΌΡΡΠ»Π΅Π½Π½ΠΎΡΡΠΈ. ΠΡΠΈ Π°Π½Π°Π»ΠΈΠ·Π΅ ΡΠ΅Π°Π»ΡΠ½ΡΡ
ΠΎΠ±ΡΠ°Π·ΡΠΎΠ² Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΡΠΎΠ½ΠΎΠ²ΡΡ
ΡΠ»Π΅ΠΊΡΡΠΎΠ»ΠΈΡΠΎΠ² ΠΌΠΎΠΆΠ½ΠΎ ΡΡΡΡΠ°Π½ΠΈΡΡ Π±Π»Π°Π³ΠΎΠ΄Π°ΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΆΠΈΠΌΠ° ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠΉ, Π±ΠΎΠ»Π΅Π΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π±ΡΡΠ΅ΡΠ½ΡΡ
ΡΠ°ΡΡΠ²ΠΎΡΠΎΠ², Π° ΡΠ°ΠΊΠΆΠ΅ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΎΡΡΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΠΎ ΠΈΠ»ΠΈ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎ Π·Π°ΡΡΠΆΠ΅Π½Π½ΡΡ
ΠΌΠ΅ΠΌΠ±ΡΠ°Π½, ΡΠΌΠ΅Π½ΡΡΠ°ΡΡΠΈΡ
Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π±ΡΡΠ΅ΡΠ½ΠΎΠΉ Π΅ΠΌΠΊΠΎΡΡΠΈ ΠΈ ΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠΈΠ»Ρ ΡΠ°ΡΡΠ²ΠΎΡΠΎΠ² ΠΈ ΡΠ°ΡΡΠΈΡΡΡΡΠΈΡ
Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½ ΡΠ°Π±ΠΎΡΡ ΡΠ΅Π½ΡΠΎΡΠΎΠ². ΠΠ»Ρ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΠΌΠΈΠ½ΠΈΠ°ΡΡΡΠ½ΡΡ
ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅Π½ΡΠΎΡΠΎΠ² ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Ρ ΡΠ»Π΅Π΄ΡΡΡΠΈΠ΅ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Ρ: Π°) ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠΎΠ»ΠΈΠ°Π½ΠΈΠ»ΠΈΠ½Π° ΠΊΠ°ΠΊ ΡΠ»Π΅ΠΊΡΡΠΎΠΏΡΠΎΠ²ΠΎΠ΄ΡΡΠ΅ΠΉ ΠΌΠ΅ΡΠΊΠΈ ΠΏΡΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ Π°Π½ΡΠΈΡΠ΅Π» Π² ΠΊΠΎΠ½ΠΊΡΡΠ΅Π½ΡΠ½ΠΎΠΌ ΠΈΠΌΠΌΡΠ½ΠΎΠ°Π½Π°Π»ΠΈΠ·Π΅; Π±) ΡΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΠΌΠ½ΠΎΠ³ΠΎΡΠ»ΠΎΠΉΠ½ΡΡ
ΡΡΡΡΠΊΡΡΡ Ρ ΠΏΠ»Π΅Π½ΠΊΠ°ΠΌΠΈ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΡΡΠ°Π»ΠΎΡΠΈΠ°Π½ΠΈΠ½Π°; Π²) ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ Π°ΠΊΡΠΈΠ»ΠΎΠ²ΡΡ
ΡΠΎ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ½ΡΡ
ΠΌΠ΅ΠΌΠ±ΡΠ°Π½. ΠΠ±ΡΡΠΆΠ΄Π΅Π½Ρ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π° ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΈ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΡΡ
ΠΊΠΎΠ½Π΄ΡΠΊΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π±ΠΈΠΎΡΠ΅Π½ΡΠΎΡΠΎΠ². ΠΠ°Π»ΡΠ½Π΅ΠΉΡΠ°Ρ ΠΊΠΎΠΌΠΌΠ΅ΡΡΠΈΠ°Π»ΠΈΠ·Π°ΡΠΈΡ, ΡΠ°ΠΊΠΈΡ
ΠΏΡΠΈΠ±ΠΎΡΠΎΠ² ΡΠ²ΡΠ·Π°Π½Π° Ρ ΠΏΠΎΠΈΡΠΊΠΎΠΌ ΠΏΡΡΠ΅ΠΉ ΡΡΠ°Π±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΠΈ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΈ ΡΠΎΠ²ΠΌΠ΅ΡΠ΅Π½ΠΈΡ, ΡΠΎΠ½ΠΊΠΎΠΏΠ»Π΅Π½ΠΎΡΠ½ΠΎΠΉ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ Ρ Π½Π°Π½Π΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ Π² Π΅Π΄ΠΈΠ½ΠΎΠΌ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΠΈΠΊΠ»Π΅
Π‘ΠΈΡΡΠ΅ΠΌΠ½Π°Ρ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΠ΅Π°ΠΊΡΠΈΡ ΠΊΠ°ΠΊ ΡΠ°ΠΊΡΠΎΡ ΠΏΡΠΎΠ³Π½ΠΎΠ·Π° ΠΏΡΠΈ ΡΠ°ΠΊΠ΅ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ. Π§Π°ΡΡΡ II. ΠΠ΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ°ΡΠΊΠ΅ΡΡ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ
Chronic inflammation is one of the recognized factors contributing to the onset and progression of malignant neoplasms. At the systemic level, a chronic inflammatory process is accompanied by an increased levels of inflammatory mediators and a change in hematological parameters of peripheral blood. According to numerous clinical studies, the change in the ratio of blood cell populations in cancer patients is an independent prognostic factor in malignant tumors of various localizations. This review is devoted to hematological parameters of the systemic inflammatory response (SIR) in breast cancer (BC). The review presents the characteristics of blood cells used for calculations of hematological indices (neutrophils, lymphocytes, monocytes, platelets); approaches for assessing SIR using these indices (NLR, PLR, LMR, etc.); comparative analysis of data on the association of the hematological indices with the clinical and morphological features of BC, patient survival and tumor response to chemotherapy. The data indicating the benefit of SIR hematological markers investigation during monitoring after treatment are summarized. Complex algorithms, including clinical, morphological and hematological factors, which are proposed to improve the quality of prognosis assessment, are considered. The information accumulated to date suggests that hematological indices reflecting SIR activity in BC patients can serve as additional independent prognostic factors. The development of the prognostic algorithms that are informative for certain clinical groups of BC patients is a promising area of research.Π₯ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΠ΅ ΠΎΠ΄ΠΈΠ½ ΠΈΠ· ΠΏΡΠΈΠ·Π½Π°Π½Π½ΡΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ², ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΡΡΠΈΡ
Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΉ. ΠΠ° ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΏΡΠΎΡΠ΅ΡΡ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π΅ΡΡΡ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ Π² ΠΊΡΠΎΠ²ΠΈ ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ ΠΈ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ. Π‘ΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΡΡ
ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΉ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΊΡΠΎΠ²ΠΈ Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
, ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΌΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ, ΡΠ²Π»ΡΠ΅ΡΡΡ Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΡΠΌ ΡΠ°ΠΊΡΠΎΡΠΎΠΌ ΠΏΡΠΎΠ³Π½ΠΎΠ·Π° ΠΏΡΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»ΡΡ
ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΠΉ. ΠΠ°ΡΡΠΎΡΡΠΈΠΉ ΠΎΠ±Π·ΠΎΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΉ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ (Π‘ΠΠ ) ΠΏΡΠΈ ΡΠ°ΠΊΠ΅ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ (Π ΠΠ). Π ΡΡΠ°ΡΡΠ΅ ΠΎΠΏΠΈΡΠ°Π½Ρ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ (Π½Π΅ΠΉΡΡΠΎΡΠΈΠ»ΠΎΠ², Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ², ΠΌΠΎΠ½ΠΎΡΠΈΡΠΎΠ², ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ²), ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΡΡΠΈΠ΅ ΠΈΡ
ΡΠ²ΡΠ·Ρ Ρ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ, ΠΈ ΡΠΏΠΎΡΠΎΠ±Ρ ΠΎΡΠ΅Π½ΠΊΠΈ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ Π‘ΠΠ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ (ΠΈΠ½Π΄Π΅ΠΊΡΡ NLR, PLR, LMR ΠΈ Π΄Ρ.). ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· Π΄Π°Π½Π½ΡΡ
ΠΎ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΡΡΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Ρ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌΠΈ Π ΠΠ, Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΡΡ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈ ΠΎΡΠ²Π΅ΡΠΎΠΌ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ Π½Π° Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ. Π Π°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ Π°Π»Π³ΠΎΡΠΈΡΠΌΡ, Π²ΠΊΠ»ΡΡΠ°ΡΡΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ°ΠΊΡΠΎΡΡ ΠΈ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΠ½Π΄Π΅ΠΊΡΡ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΏΡΠ΅Π΄Π»Π°Π³Π°ΡΡΡΡ Π΄Π»Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ. ΠΠ°ΠΊΠΎΠΏΠ»Π΅Π½Π½ΡΠ΅ Π½Π° ΡΠ΅Π³ΠΎΠ΄Π½ΡΡΠ½ΠΈΠΉ Π΄Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ ΡΠΎΠΌ, ΡΡΠΎ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΠ½Π΄Π΅ΠΊΡΡ, ΠΎΡΡΠ°ΠΆΠ°ΡΡΠΈΠ΅ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π‘ΠΠ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π ΠΠ, ΠΌΠΎΠ³ΡΡ ΡΠ»ΡΠΆΠΈΡΡ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΌΠΈ Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΡΠΌΠΈ ΡΠ°ΠΊΡΠΎΡΠ°ΠΌΠΈ ΠΏΡΠΎΠ³Π½ΠΎΠ·Π° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ. Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π°Π»Π³ΠΎΡΠΈΡΠΌΠΎΠ², ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠ²Π½ΡΡ
Π΄Π»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π³ΡΡΠΏΠΏ Π±ΠΎΠ»ΡΠ½ΡΡ
Π ΠΠ, ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ
Π‘ΠΈΡΡΠ΅ΠΌΠ½Π°Ρ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΠ΅Π°ΠΊΡΠΈΡ ΠΊΠ°ΠΊ ΡΠ°ΠΊΡΠΎΡ ΠΏΡΠΎΠ³Π½ΠΎΠ·Π° ΠΏΡΠΈ ΡΠ°ΠΊΠ΅ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ. Π§Π°ΡΡΡ I. ΠΠΏΡΡ ΠΎΠ»Ρ-ΠΏΡΠΎΠΌΠΎΡΠΈΡΡΡΡΠ΅Π΅ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΠ΅. Π‘ΡΠ²ΠΎΡΠΎΡΠΎΡΠ½ΡΠ΅ ΠΌΠ°ΡΠΊΠ΅ΡΡ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ
Chronic inflammation caused by exposure to external or internal factors increases the risk of developing malignancies and promotes tumor progression due to the influence on the key elements of carcinogenic mechanisms. At the system level signs of a chronic inflammation are manifested by an increase of inflammatory mediators and acute phase proteins levels in the blood, a change in the ratio of circulating leukocyte populations, and disturbances in the hemostasis system. This review is devoted to serum and hematological parameters of the systemic inflammatory response (SIR) in breast cancer (BC). The first part of the review outlines general concept about the role of inflammatory factors in the development of malignant tumors. It provides information on the most well studied serum inflammatory markers in breast cancer: cytokines, including interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-), as well as C-reactive protein (CRP). The main properties of these polypeptides, which link them with tumor-promoting inflammation, are considered. An analysis of the data on the clinical significance of the serum level of cytokines and CRP in breast cancer accumulated to date is presented. Correlations of the elevated levels of the serum inflammatory markers with clinical and morphological characteristics of the disease, tumor response to chemotherapy, overall and relapse-free survival of patients indicate the feasibility of in-depth investigation of the issue for the purpose of the practical application of the systemic inflammatory markers as predictive and prognostic indicators in BC.Π₯ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΠ΅, Π²ΡΠ·Π²Π°Π½Π½ΠΎΠ΅ Π²ΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ΠΌ Π²Π½Π΅ΡΠ½ΠΈΡ
ΠΈΠ»ΠΈ Π²Π½ΡΡΡΠ΅Π½Π½ΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ², ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°Π΅Ρ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΉ ΠΈ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΠ΅Ρ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΠΈ, ΠΎΠΊΠ°Π·ΡΠ²Π°Ρ ΠΏΡΠΎΠΌΠΎΡΠΈΡΡΡΡΠ΅Π΅ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ Π½Π° Π²Π΅Π΄ΡΡΠΈΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π·Π²Π΅Π½ΡΡ ΠΊΠ°Π½ΡΠ΅ΡΠΎΠ³Π΅Π½Π΅Π·Π°. ΠΡΠΈΠ·Π½Π°ΠΊΠΈ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° Π½Π° ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅ ΠΏΡΠΎΡΠ²Π»ΡΡΡΡΡ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ Π² ΠΊΡΠΎΠ²ΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ ΠΈ Π±Π΅Π»ΠΊΠΎΠ² ΠΎΡΡΡΠΎΠΉ ΡΠ°Π·Ρ, ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΡ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΉ ΡΠΈΡΠΊΡΠ»ΠΈΡΡΡΡΠΈΡ
Π»Π΅ΠΉΠΊΠΎΡΠΈΡΠΎΠ², Π½Π°ΡΡΡΠ΅Π½ΠΈΡΠΌΠΈ ΡΠΎ ΡΡΠΎΡΠΎΠ½Ρ ΡΠΈΡΡΠ΅ΠΌΡ Π³Π΅ΠΌΠΎΡΡΠ°Π·Π°. ΠΠ°ΡΡΠΎΡΡΠΈΠΉ ΠΎΠ±Π·ΠΎΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΠΌ ΡΡΠ²ΠΎΡΠΎΡΠΎΡΠ½ΡΡ
ΠΈ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΉ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ (Π‘ΠΠ ) ΠΏΡΠΈ ΡΠ°ΠΊΠ΅ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ (Π ΠΠ). Π ΠΏΠ΅ΡΠ²ΠΎΠΉ ΡΠ°ΡΡΠΈ ΠΎΠ±Π·ΠΎΡΠ° ΠΈΠ·Π»ΠΎΠΆΠ΅Π½Ρ ΠΎΠ±ΡΠΈΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΎ ΡΠΎΠ»ΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΎ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Ρ
ΠΎΡΠΎΡΠΎ ΠΈΠ·ΡΡΠ΅Π½Π½ΡΡ
ΠΏΡΠΈ Π ΠΠ ΡΡΠ²ΠΎΡΠΎΡΠΎΡΠ½ΡΡ
ΠΌΠ°ΡΠΊΠ΅ΡΠ°Ρ
Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ: ΡΠΈΡΠΎΠΊΠΈΠ½Π°Ρ
ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π΅-6 (ΠΠ-6), ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π΅-8 (ΠΠ-8), ΡΠ°ΠΊΡΠΎΡΠ΅ Π½Π΅ΠΊΡΠΎΠ·Π° ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ-Π°Π»ΡΡΠ° (Π€ΠΠ-), Π° ΡΠ°ΠΊΠΆΠ΅ Π‘-ΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΠΎΠΌ Π±Π΅Π»ΠΊΠ΅ (Π‘Π Π). Π Π°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡΡΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΡΡΠΈΡ
ΠΏΠΎΠ»ΠΈΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ², ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠ΅ ΠΈΡ
Ρ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ°ΠΌΠΈ ΠΎΠΏΡΡ
ΠΎΠ»Ρ-ΠΏΡΠΎΠΌΠΎΡΠΈΡΡΡΡΠ΅Π³ΠΎ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ. ΠΡΠΈΠ²ΠΎΠ΄ΠΈΡΡΡ Π°Π½Π°Π»ΠΈΠ· Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½Π½ΡΡ
Π½Π° ΡΠ΅Π³ΠΎΠ΄Π½ΡΡΠ½ΠΈΠΉ Π΄Π΅Π½Ρ Π΄Π°Π½Π½ΡΡ
ΠΎ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ ΡΡΠ²ΠΎΡΠΎΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΡΠΎΠ²Π½Ρ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈ Π‘Π Π ΠΏΡΠΈ Π ΠΠ. ΠΠ°Π±Π»ΡΠ΄Π°Π΅ΠΌΡΠ΅ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΈ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° Ρ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ°ΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, ΡΠ°ΡΡΠΎΡΠΎΠΉ ΠΎΡΠ²Π΅ΡΠ° Π½Π° Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ, ΠΎΠ±ΡΠ΅ΠΉ ΠΈ Π±Π΅Π·ΡΠ΅ΡΠΈΠ΄ΠΈΠ²Π½ΠΎΠΉ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΡΡ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ ΡΠ΅Π»Π΅ΡΠΎΠΎΠ±ΡΠ°Π·Π½ΠΎΡΡΠΈ ΡΠ³Π»ΡΠ±Π»Π΅Π½Π½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΡΠΈΡΡΠ΅ΠΌΠ½ΡΡ
ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ ΠΏΡΠΈ Π ΠΠ Ρ ΡΠ΅Π»ΡΡ ΠΈΡ
ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠ°ΠΊ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΈΠ²Π½ΡΡ
ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ
SCIENTIFIC SUBSTANTIATION OF THE CONCEPTION OF CONTINUOUS ECONOMIC EDUCATION DEVELOPMENT
The Conception of continuous economic education development developed by us is based on the idea of continuous education, in which economic education is considered as an important structural element in the conditions of the new Russian developing economy. As a result of Russia's transition to a market economy, there is an urgent need for economic training of specialists who successfully work in the new socio-economic conditions, quickly and adequately responding to the changing market conditions. Economic education is aimed at the formation of economic competencies (key, professional and additional), and economic training is carried out in order to: the formation of economic thinking; development of business qualities of an economically educated person; accumulation of knowledge in the field of economy, management, taxation. In the conditions of market type economy professional education is focused on formation of the competitive, demanded in the labor market specialist possessing necessary economic competences which are formed in the course of economic training and economic education including knowledge of the objective economic laws and categories system; formation of economic competences and their realization in economic behavior; development of business qualities of the economically educated person; accumulation of knowledge in the field of economy, management, and taxation. The analysis of the classifications of competencies on various grounds allowed us to develop a structure of economic competence of students, including key, professional, and additional economic competences. The Conception of continuous economic education development developed by us takes into account the idea of continuing education, in which continuing economic education becomes an important structural element of vocational education in the conditions of the new Russian developing economy
The development of the higher education services market as a priority direction of the professional school modernization
Introduction. The quality of professional education is a complex multi-level and dynamic system of qualities oriented on preparing a graduate who is in demand in the labor market. Research Methodology. The article's authors share P.F. Drucker's point of view, who believed that a system management should go in accordance with the plurality of its goals, and the efficiency of this process is measured, alongside with other factors, by the balance of the organizational goals. Research Results. The educational system of higher school is a kind of social economical system functioning on the scale of: micro-level (an educational institution); meso-level (a regional educational system); national level (the educational system of the Russian Federation); world level (global educational space). Discussion. In the Russian Federation, state control over statutory compliance in the higher school rests with the federal center and strictly follows timeframes. However, control and estimating procedures are neither comprehensive nor free from drawbacks. Besides, the process of state control over the education quality depends on a number of factors. Conclusion. Lack of due attention to the problems of education quality can lead to certain disproportions in the education services market. Β© 2018
Clinical significanse of prostate-specific antigen in breast cancer patients
Background. Prostate-specific antigen (PSA) is predominantly produced by prostate epithelium, however, other tissues can serve as its minor sources in both men and women, including breast tissue. In women, elevated serum PSA levels have been described in different physiological and pathological conditions, including benign breast diseases and breast cancer (BC). PSA is considered as a potential serum tumor marker for BC, but evidences of its possible clinical significance are insufficiently convincing. Aim of the study: investigation of PSA levels in female BC patients and assessment of perspectives of its study as a diagnostic tool for early detection of BC. Material and methods. Serum PSA levels were measured by chemiluminescence immunoassay (ARCHITECT, Abbott) in 99 female patients with histologically confirmed BC (carcinoma in situ - 11, stage I - 56, stage IIA - 32) and 25 conditionally healthy female donors. Results. In the donor group, serum PSA was revealed in 22/25 (88,0 %) cases, and its mean level was 4.0 Β± 0.9 ng/l. In the group of BC patients, detectable PSA level was revealed in 68/99 (68.7 %) cases, and its mean level was 2.8 Β± 0.9 ng/l. Differences between groups of BC patients and donors in mean marker values were not statistically significant (p>0,05). Serum PSA levels were higher in young women: in the group of BC patients under 40 years old, percentage of PSA -positive cases was 89 %, in the group of patients over 50 years old - 60 %; in groups of donors under 40 and over 50 years old - 100 % and 80 %, respectively. In cases of in situ carcinoma, the mean serum PSA was higher than in cases with stages I and II (3.0 Β± 1.2 ng/l vs 1.9 Β± 0.3 ng/l and 1.6 Β± 0.3 ng/l, respectively; p>0,05). In the group of BC patients, no PSA levels were found to be dependent on the histological type, grade and molecular subtype of the tumor. Conclusion. The PSA level has no clinical significance in early stages of BC, since the proportion of cases with elevated PSA levels and itβs mean value in patients with early stages of BC donβt differ from those in the group of healthy women. Β© 2020, Tomsk National Research Medical Center of the Russian Academy of Sciences. All rights reserved
O Π½ΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΡΡΠΎΠ²Π½Ρ KIM-1 Π½Π° ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΊΡΠ΅Π°ΡΠΈΠ½ΠΈΠ½Π° Π² ΠΌΠΎΡΠ΅ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΏΠΎΡΠ΅ΡΠ½ΠΎ-ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΌ ΡΠ°ΠΊΠΎΠΌ [On normalizing of urinary KIM-1 level to urine creatinine in patients with renal cell cancer]
KIM-1 (kidney injury molecule 1), a marker of acute kidney injury, is produced by epithelial cells of renal proximal tubules. Elevated KIM-1 levels in urine and plasma are associated with renal cell carcinoma (RCC). The aim of this study was to compare the significance of non-normalized uKIM-1 values and those normalized to urine creatinine, as urinary biomarkers in RCC. The uKIM-1, urine creatinine and their ratio (uKIM-1/Cre) were studied in 118 RCC patients and 58 apparently healthy subjects. The median of uKIM-1 in the healthy group was 0.71 ng/ml (1st and 3rd quartiles were 0.35 and 1.23, respectively) and in RCC patients it was 2.36 (1.43; 5.93) ng/ml. The medians of uKIM-1/Cre were 0.77 (0.49; 1.18) and 2.42 (1.41; 4.61) ng/mgCre, respectively. Stage I RCC is statistically significantly different from stages II-III and stage IV using uKIM-1/Cre values (p = 0.0056 and p = 0.0012, respectively); using uKIM-1 values significant differences occur only when comparing stages I and IV (p = 0.015). In both healthy individuals and RCC patients, uKIM-1/Cre levels were slightly lower in subgroups younger than 50 years than in subgroups older than 50 years, whereas a similar trend was observed for uKIM-1 only in patients. In healthy men and male patients, uKIM-1 levels were higher than in the corresponding groups of women (the differences were not statistically significant), but the use of uKIM-1/Cre values eliminated the gender differences. A high correlation was found between the concentrations of uKIM-1 and urine creatinine in three healthy subjects followed up for 3 weeks (Spearman's correlation coefficients were 0.758, 0.825 and 0.933, respectively). The data obtained are clear evidence of the need for normalization uKIM-1 to urine creatinine in RCC patients
The development of the higher education services market as a priority direction of the professional school modernization
Introduction. The quality of professional education is a complex multi-level and dynamic system of qualities oriented on preparing a graduate who is in demand in the labor market. Research Methodology. The article's authors share P.F. Drucker's point of view, who believed that a system management should go in accordance with the plurality of its goals, and the efficiency of this process is measured, alongside with other factors, by the balance of the organizational goals. Research Results. The educational system of higher school is a kind of social economical system functioning on the scale of: micro-level (an educational institution); meso-level (a regional educational system); national level (the educational system of the Russian Federation); world level (global educational space). Discussion. In the Russian Federation, state control over statutory compliance in the higher school rests with the federal center and strictly follows timeframes. However, control and estimating procedures are neither comprehensive nor free from drawbacks. Besides, the process of state control over the education quality depends on a number of factors. Conclusion. Lack of due attention to the problems of education quality can lead to certain disproportions in the education services market. Β© 2018
DESIGN CULTURE OF R&D PROJECT SPECIALIST IN THE LIGHT INDUSTRY
A fashion designer (FD) is a person who plays a key role in creating new variants of clothing, shoes, hats and other things of this kind (including accessories). The professional patterns proposed by this worker determine the fit, the potential demand and other important characteristics of the product. Previously, the designer was a specialist who combined a number of professional functions: he/she was responsible for the choice of fabric, the style, the cutting and the sewing. However, in the future many tasks were distributed among other employees: designer, cutter and tailor. Therefore, the FD's functions have significantly decreased. Currently his/her duties include studying fashion trends, formulating fresh ideas and creating sketches. The technologist processes fabrics, modernizes the production process and improves the tailoring technique. The constructor deals with drawings, i.e. is involved in both technical and artistic aspects of the activity. As a rule, these specialists work together in a team, making a common contribution to the creation of new collections. As for the FD, in most cases he/she is engaged in a ready-made sketch developed by the constructor. In other words, the former is obliged to realize the latter's creative idea, turn it into a tangible and visible object with the lowest material and technical costs. The FD decides which fabric should be used for a particular model, deals with patterns and templates, provides various approaches to the implementation of the original plan. Thus, we are talking about activities of technical nature with an element of creativity, which requires special education and specific professional skills